Nuvation Bio is trading at $5.00, up 6.61%, in line with pre-market gains across major indexes. - The S&P 500 was up 0.87%, Nasdaq Composite 0.93%, and Dow Jones Industrial Average 1.26%. - Nuvation Bio is scheduled to report third-quarter results and provide a business update on November 4, 2026, at 4:30 p.m. ET, after the regular session; results were not yet available at 5:15 a.m. - No overnight company-specific announcement explaining the pre-market rise was identified.